NAD+
Nicotinamide Adenine Dinucleotide
NAD+ is a vital coenzyme present in every cell that plays crucial roles in energy metabolism, DNA repair, and cellular aging processes. As NAD+ levels naturally decline with age (by ~50% by age 50), supplementation through IV therapy or injections aims to restore cellular energy production, activate longevity pathways through sirtuin proteins, and support mitochondrial health. Research demonstrates significant improvements in cognitive function, physical performance, and biomarkers of aging.
Complete Research Database
Adverse Event Frequencies (Clinical Trials)
Clinical Safety Notes
- •GI side effects typically occur during dose escalation
- •Most adverse events are mild to moderate in severity
- •Discontinuation rate due to side effects: ~5.3%
- •No increased risk of pancreatitis in clinical trials
- •Regular monitoring recommended for thyroid function
Medical Disclaimer
NAD+ therapy is currently in research phase and not FDA-approved for specific medical conditions. This information is for educational purposes and should not replace consultation with qualified healthcare providers. Individual results may vary significantly. Professional medical supervision is recommended for all NAD+ therapeutic protocols.